Richard Lindahl

Richard Lindahl

Executive Vice President, Chief Financial OfficeratEmergent BioSolutions· In proxies 2021–2025

Pay in FY2025+17% from the year before

Richard Lindahl was paid $2.7M in FY2025 (Dec), up 17%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Emergent BioSolutions proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Emergent BioSolutionsPublic company · 5 yr
    • Executive Vice President, Chief Financial Officer2021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?